Nitric Oxide Donors [donory oxidu dusnatého]

topical
63
Terms

donor oxidu dusnatého
oxid dusnatý - donory

 

Nitric Oxide Donor

Persistent link   https://www.medvik.cz/link/D020030
Definition

A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81)

DUI
D020030 MeSH Browser
CUI
M0029737
Previous indexing
Nitric Oxide (1990-1998)
History note
1999
Public note
1999

Allowable subheadings

AD
administration & dosage 7
AE
adverse effects 2
AG
agonists
AN
analysis 1
AI
antagonists & inhibitors 1
BL
blood
CF
cerebrospinal fluid
CS
chemical synthesis
CH
chemistry 2
CL
classification
EC
economics
HI
history
IM
immunology
IP
isolation & purification
ME
metabolism 4
PK
pharmacokinetics 1
PD
pharmacology 23
PO
poisoning
RE
radiation effects
ST
standards
SD
supply & distribution
TU
therapeutic use 9
TO
toxicity
UR
urine

D Chemicals and Drugs
D27 Chemical Actions and Uses 374
D27.505 Pharmacologic Actions 409
D27.505.519 Molecular Mechanisms of Pharmacological Action 89
D27.505.519.124 Alkylating Agents 91
D27.505.519.143 Amylin Receptor Agonists
D27.505.519.162 Angiotensin Receptor Antagonists 223
D27.505.519.170 Antacids 162
D27.505.519.174 Antidiuretic Hormone Receptor Antagonists 28
D27.505.519.178 Antifoaming Agents 12
D27.505.519.182 Antiglycation Agents
D27.505.519.186 Antimetabolites 120
D27.505.519.217 Antioxidants 2 531
D27.505.519.241 Aversive Agents
D27.505.519.265 Bradykinin Receptor Antagonists 10
D27.505.519.270 Calcitonin Gene-Related Peptide Receptor Antagonists 74
D27.505.519.275 CCR5 Receptor Antagonists 4
D27.505.519.295 Cerumenolytic Agents 1
D27.505.519.334 Cystine Depleting Agents
D27.505.519.349 Cytochrome P-450 Enzyme Inducers 10
D27.505.519.364 Endothelin Receptor Antagonists 121
D27.505.519.374 Enzyme Activators 30
D27.505.519.389 Enzyme Inhibitors 881
D27.505.519.405 Enzyme Reactivators 16
D27.505.519.421 Fibrin Modulating Agents 2
D27.505.519.452 Heparin Antagonists 23
D27.505.519.507 Immune Checkpoint Inhibitors 360
D27.505.519.562 Membrane Transport Modulators 22
D27.505.519.593 Mitosis Modulators 3
D27.505.519.625 Neurotransmitter Agents 517
D27.505.519.656 Nitric Oxide Donors 63
D27.505.519.828 Peptidomimetics 11
D27.505.519.871 Radiopharmaceuticals 808
D27.505.519.914 Sequestering Agents 1
D27.505.519.936 Sodium-Glucose Transporter 2 Inhibitors 794
D27.505.519.947 Sphingosine 1 Phosphate Receptor Modulators 27
D27.505.519.952 Toll-Like Receptor Agonists
D27.505.519.957 Viral Fusion Protein Inhibitors
D27.505.954 Therapeutic Uses 61
D27.505.954.411 Cardiovascular Agents 475
D27.505.954.411.097 Anti-Arrhythmia Agents 1 139
D27.505.954.411.162 Antihypertensive Agents 3 012
D27.505.954.411.192 Calcium Channel Blockers 1 284
D27.505.954.411.207 Cardioplegic Solutions 36
D27.505.954.411.222 Cardiotonic Agents 225
D27.505.954.411.320 Fibrinolytic Agents 523
D27.505.954.411.455 Natriuretic Agents 8
D27.505.954.411.590 Nitric Oxide Donors 63
D27.505.954.411.645 Potassium Channel Blockers 65
D27.505.954.411.700 Sclerosing Solutions 65
D27.505.954.411.720 Sodium Channel Blockers 42
D27.505.954.411.793 Vasoconstrictor Agents 221
D27.505.954.411.918 Vasodilator Agents 800

Back Add